Skip to main content

Profound Medical Corp.

PROF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001628808

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Profound Medical Corp. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of PROF: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders4239−3
Shares9.52M9.52M+1.36K (0.0%)
Value$80.3M$80.1M−$155.7K (−0.2%)

New holders (4)

Institutions that held Profound Medical Corp. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to PROF in Q2 2024
InstitutionSharesValue% of portfolio
Neuberger Berman Group LLC13,550$113.7K0.00%
Raymond James Trust N.A.10,500$88.1K0.00%
PenderFund Capital Management Ltd.7,300$85.6K0.02%
Group One Trading, L.P.1$80.00%

Sold out (7)

Institutions that held Profound Medical Corp. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of PROF in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Zweig-DiMenna Associates LLC104,261$889.3K
Renaissance Technologies LLC18,700$160.0K
Goldman Sachs Group Inc16,700$142.5K
Citadel Advisors LLC10,607$90.5K
Harbor Investment Advisory, LLC250$2.13K
CWM, LLC100$1.00K
Tower Research Capital LLC (TRC)103$879